Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
NSAID use and dementia risk in the Cardiovascular Health Study*
2007
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
2011
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
1997 StandoutNature
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland
1999
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
2006
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
1997 Standout
Dietary Fish Oil and Insulin Action in Humans
1993
The metabolic syndrome
2010 Standout
Mechanisms of pH Regulation in the Regulated Secretory Pathway
2001 StandoutNobel
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
1997
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
The Homocysteine Hypothesis of Depression
2007
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
The cat as a model for human nutrition and disease
2006
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
1998
The metabolic syndrome
2005 Standout
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Graves' Ophthalmopathy
2010 Standout
The Ectodomain of the Luteinizing Hormone Receptor Interacts with Exoloop 2 to Constrain the Transmembrane Region
2002 StandoutNobel
Neurodegeneration and Inflammation
2008
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Hospitalization costs associated with warfarin‐related bleeding events among older community‐dwelling adults
2010
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Beyond the Prescription: Medication Monitoring and Adverse Drug Events in Older Adults
2011
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm� feasibility study
1991
Alzheimer's Disease
2010 Standout
Major Depressive Disorder
2008 Standout
Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region
2000 StandoutNobel
Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid
1987
Myocarditis
2000 Standout
Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus
2003
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Innovative Drug Treatments for Viral and Autoimmune Myocarditis
1998
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα
1993 StandoutNatureNobel
The direct and indirect effects of insulin on hepatic glucose production in vivo
1998
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
2001 Standout
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
2003
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Placebo interventions for all clinical conditions
2004
Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation
1997 StandoutNobel
Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
2000
Role of leptin in the neuroendocrine response to fasting
1996 StandoutNature
A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes
2002
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Magnesium and blood pressure: Review of the epidemiologic and clinical trial experience
1989
Lessons from the glitazones: a story of drug development
2001
Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
2008
Mitosis in rat thyroid epithelial cells in vivo
1979
A prospective study of nutritional factors and hypertension among US men.
1992
Effects of Food Deprivation on the Feedback Regulation of the Hypothalamic-Pituitary-Thyroid Axis of the Rat*
1985
Adrenal Innervation May Be an Extrapituitary Mechanism Able to Regulate Adrenocortical Rhythmicity in Rats*
1982
Vasoactive Intestinal Peptide: A Novel Stimulator of Steroidogenesis by Cultured Rat Granulosa Cells1
1985
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis
1994
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
2011 StandoutScience
Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.
1988
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα
2018
Activation of Orphan Receptors by the Hormone Relaxin
2002 StandoutScience
Toxicity of β-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations
1994
The lamin B receptor of the inner nuclear membrane undergoes mitosis-specific phosphorylation and is a substrate for p34cdc2-type protein kinase.
1992 StandoutNobel
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Placebo interventions for all clinical conditions
2010
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.
1996 StandoutNobel
Multicomponent intermetallic nanoparticles and superb mechanical behaviors of complex alloys
2018 StandoutScience
The Need for Glycemic Trials in Type 2 Diabetes
2003
Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane.
1988
Progressive Recruitment of Follicular Cells with Graded Secretory Responsiveness during Stimulation of the Thyroid Gland by Thyrotropin*
1987
Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies
1997
Smoking and Risk of Graves' Disease
1993
Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes.
1987
The Metabolic Syndrome
2008 Standout
Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
2004
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
1981
Precipitation hardening
1985 Standout
Preventing Non-Insulin-Dependent Diabetes
1995
Development of diabetes in Japanese subjects with impaired glucose tolerance: A seven year follow-up study
1982
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Endocrine function in human obesity
1981
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Management of Graves' Ophthalmopathy: Reality and Perspectives
2000
Works of Arne Melander being referenced
Interactions between Catecholamines, 5-Hydroxytryptamine and TSH on the Secretion of Thyroid Hormone
1972
Sulphonylurea dose–response relationships: relation to clinical practice
2000
Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years
2003
Retinopathy in subjects with impaired fasting glucose: the NANSY‐Eye baseline report
2007
Antihyperglycaemic Efficacy, Response Prediction and Dose—Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination
1994
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study
2000
Laxative treatment elevates plasma homocysteine: a study on a population-based Swedish sample of old people
2004
Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes
1999
Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population
2001
Influence of beta‐adrenoceptor blocking agents on lymphocyte function in vitro.
1982
In VivoAction of Vinblastine on Thyroid Ultrastructure and Hormone Secretion
1974
Clinical pharmacology of sulfonylureas
1987
Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study
1994
Transplacental passage of atenolol in man
1978
Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease
1977
Peroxisome proliferator-activated receptor-??Pro12Ala polymorphism and the association with blood pressure in type 2 diabetes
2003
Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care
2007
Induced Unidirectional Transport of Protein into the Thyroid Follicular Lumen
1974
Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects
1987
Sympathetic Activation of Thyroid Hormone Secretion in Mice
1972
Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project.
2003
The strength of a precipitation hardened AlZnMg alloy
1978
Metabolic Consequences of Sustained Suppression of Free Fatty Acids by Acipimox in Patients With NIDDM
1993
Blood Levels of 3,5,3‘‐Triiodothyronine and Thyroxine: Differences between Children, Adults, and Elderly Subjects
1976
Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment
1987
What Is the Benefit of Increasing the Sulfonylurea Dose?
1993
Sulfonylureas Why, Which, and How?
1990
How to screen for diabetes mellitus
1983
Impaired effect of sulfonylurea following increased dosage
1982
Mortality in elderly men with low psychosocial coping resources using anxiolytic - hypnotic drugs
2000
Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans
1991
Intracellular distribution of amines and calcitonin in the sheep thyroid gland
1972
Presence and Influence of Cholinergic Nerves in the Human Thyroid*
1980
STIMULATION OF PERIPHERAL T3 FORMATION BY ORAL BUT NOT BY INTRAVENOUS GLUCOSE ADMINISTRATION IN FASTED SUBJECTS
1977
Effects of Total Energy Withdrawal (Fasting) on the Levels of Growth Hormone, Thyrotropin, Cortisol, Adrenaline, Noradrenaline, T4, T3, and rT3 in Healthy Males
1977
Influence of Cigarette Smoking on Goiter Formation,Thyroglobulin, and Thyroid Hormone Levels in Women*
1984
Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation
1980
Comparison of Energy and Nutrient Intakes in Women with High and Low Blood Pressure Levels
1980
On the critical resolved shear stress from misfitting particles
1978
Comparison of Pharmacokinetics, Metabolic Effects and Mechanisms of Action of Glyburide and Glipizide During Long-Term Treatment
1987
Sympathetic Innervation of the Thyroid: Variation with Species and with Age
1975
Vasoactive Intestinal Peptide Stimulation of Human Thyroid Cell Function*
1984
Will Sulfonylurea Treatment of Impaired Glucose Tolerance Delay Development and Complications of NIDDM?
1990